Prof. Dr. Mark Pletscher

MSc Interprofessionelles und Forschungsmodule, Gesundheitspolitik und -ökonomie

CAS Gesundheitsökonomie und Public Health 19-20

Wieser, S., M. Riguzzi, M. Pletscher, C.A. Huber, H. Telser, M. Schwenkglenks (2018): "How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts". The European Journal of Health Economics, online first.

Girardin, F., A. Poncet, A. Perrier, M. Pletscher, F. Samer, J.A. Liebermann, J. Villard (2018): "Cost-effectiveness of HLA-DQB1/HLA-B pharmacogeneticguided treatment and blood monitoring in US patients taking clozapine". Pharmacogenomics, online first.

Pletscher, M. (2017): "The effects of organized screening programs on the demand for mammography". The European Journal of Health Economics, 18(5), 649-665.

Gencer, B., N. Rodondi, R. Auer, D. Nanchen, L. Räber, R. Klingenberg, M. Pletscher, P. Jüni, S. Windecker, C.M. Matter, T.F. Lüscher, F. Mach, T.V. Perneger, F.R. Girardin (2016): "Health utility indexes in patients with acute coronary syndromes". Open Heart, 3(1).

Pletscher, M., S. Walker, K. Moschetti, C. Pinget, J.-B. Wasserfallen, J.P. Greenwood, J. Schwitter, F. Girardin (2016): "Cost-effectiveness of functional cardiac imaging in the diagnostic work-up of coronary heart disease". The European Heart Journal - Quality of Care and Clinical Outcomes, in press, doi:10.1093/ehjqcco/qcw008.

Pletscher, M. (2015): "Marginal revenue and length of stay in inpatient psychiatry". The European Journal of Health Economics, 17(7), 897-910.

Pletscher, M., R. Mattli, O. Reich, A. von Wyl, S. Wieser (2014): "The societal costs of schizophrenia in Switzerland". The Journal of Mental Health Policy and Economics, 18(2), 93-103.

Pletscher, M., R. Plessow, K. Eichler, S. Wieser (2013): "Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland". Swiss Medical Weekly, 143, w13732.

Wieser, S., I. Rüthemann, S. De Boni, K. Eichler, M. Pletscher, D. Radovanovic, T. Ulle, H. Auerbach (2012): "Cost of acute coronary syndrome in Switzerland in 2008". Swiss Medical Weekly, 142, w13655.

Pletscher, M. (2017): "The effects of organized mammography screening on breast cancer mortality in Switzerland - Early evidence from a natural experiment". Working paper, September 2017.

Wieser, S., M. Riguzzi, M. Pletscher, M. Dettling (2014): "Development of a prospective payment system for inpatient psychiatry in Switzerland". Report on behalf of the Swiss Association of Hospitals, H+.

Wieser, S., Y. Tomonaga, M. Riguzzi, B. Fischer, H. Telser, M. Pletscher, K. Eichler, M. Trost, M. Schwenkglenks (2014): "The costs of non-communicable diseases in Switzerland". Report on behalf of the Swiss Federal Office of Public Health.

Pletscher, M.(2012): "Health Literacy and Outpatient Service Use in Switzerland". The Geneva Association Health and Ageing Newsletter, 27.

Pletscher, M., S. Wieser (2012): "The use of methylphenidate in children and adolescents: Insurance claims data shows increase between 2005 and 2008". BAG Bulletin, 26 443-446.

Wieser, S., R. Schleiniger, M. Pletscher, R. Plessow, U. Brügger (2011): "Unified health insurance funds: Economic assessment of the advantages and drawbacks". Report on behalf of the Conference of Cantonal Health Directors, eastern Switzerland.

Hess, S., M. Pletscher, K. Eichler, U. Brügger (2010): "Update of the economic literature on a healthy body weight". Report on behalf of Health Promotion Switzerland.

Wieser, Simon, L. Kauer, S. Schmidhauser, M. Pletscher, U. Brügger, C. Jeanrenaud, S. Flügister-Dousse, D. Kohler, J. Marti (2009): "Economic evaluation on health promotion and prevention in Switzerland". Synthesis report on behalf of the Swiss Federal Office of Public Health.

Kauer, Lukas, M. Pletscher, S. Wieser, U. Brügger (2009): "Assessment of the availability and quality of Swiss data required to conduct a full CBA in the field of obesity prevention - Part II of the project ’Exploratory study on obesity: Economic evaluation on health promotion and prevention’. Report on behalf of the Swiss Federal Office of Public Health.

Szvircsev, T, A. Wenger, S. Würmli, M. Pletscher and U. Wenger (2009): "Security 2009: Trends in the public perception of foreign, security and defence policy". Swiss Military Academy at ETH Zurich.

Pletscher, M., S. Gsteiger (2019): "Discrete time restricted cubic spline models for network meta-analysis of time-to-event outcomes". Poster preseted at ISPOR 22nd Annual European Congress: November 2019, Copenhagen.

Loughran, T., A. Reyes, M. Pletscher, T. Krivasi, A.J. Hatswell (2017): "Mapping from SF-36 Trial Data To EQ-5D Utilities in Advanced Basal Cell Carcinoma". Poster presented at ISPOR 20th Annual European Congress: November 2017, Glasgow.

Pletscher, M., M. Carreras, A. Wong, R. Doshi (2016): "Don’t Put Off Until Tomorrow What You Can Do Today: Cost-Effectiveness of Trastuzumab Plus Paclitaxel Combination Therapy and Sequential use of Paclitaxel and Trastuzumab in the Treatment of Metastatic Breast Cancer in Singapore". Poster presented at ISPOR 7th Asia-Pacific Conference: September 2016, Singapore.

Pletscher, M., R. Mattli, K. Eichler, S. Wieser (2013): "Inpatient hospital costs of febrile neutropenia as a consequence of chemotherapy for breast cancer and Non-Hodgkin lymphoma in Switzerland". Poster presented at ISPOR 16th Annual European Congress: November 2013, Dublin.

Wieser, S., P. Brühlmann, D. Kyburz, R. Plessow, M. Pletscher, U. Brügger (2010): "Cost-effectiveness of Tocilizumab in Switzerland: A microsimulation approach". Poster presented at SGR Annual Congress, 9. September 2010, Fribourg.

Pletscher, M, S. Gsteiger (2019): "Discrete time restricted cubic spline models for network meta-analysis of time-to-event outcomes" Poster presented at ISPOR Annual European Congress: November 2019, Copenhagen.

2012 - present: The Nursing Science Foundation Switzerland, Basel - Member of the scientific committee

2009 - 2017: Management, Information and Communication Training staff, Swiss Military - Communication skills trainer, module developer